medigraphic.com
SPANISH

Medicina Cutánea Ibero-Latino-Americana

ISSN 0210-5187 (Electronic)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2009, Number 6

<< Back Next >>

Med Cutan Iber Lat Am 2009; 37 (6)

Systemic sclerosis and breast cancer

Vallés L, Arrue I, González M, Valverde R, Polo I, Guerra A, Vanaclocha F
Full text How to cite this article

Language: Spanish
References: 16
Page: 258-261
PDF size: 240.04 Kb.


Key words:

neoplasia, scleroderma, connective tissue disease.

ABSTRACT

Several studies have demonstrated an increase in cancer in patients with systemic sclerosis (SS) especially lung cancer, but also breast cancer. We present a rapidly progressive SS, in a 70 years old woman, with early systemic affectation and left breast induration. Mammography and several biopsies diagnosed a breast adenocarcinoma. The duration between SS onset and breast cancer diagnosis was 9 months.


REFERENCES

  1. Duncan SC, Winkelmann RK. Cancer and Scleroderma. Arch Dermatol 1979; 115: 950-5.

  2. Sakauchi F, Mori M, Ishikawa O, Endo H. The association of systemic sclerosis with malignant neoplasms. Nihon Rinsho Meneki Gakkai Kaishi 2004; 27: 402-6.

  3. Roumm A, Medsger TA. Cancer and systemic sclerosis. An epidemiologic study. Arthritis Rheum 1985; 28: 1336-40.

  4. Abu-Shakra M, Guillemin F, Lee P. Cancer in systemic sclerosis. Arthritis Rheum 1993; 36: 460-4.

  5. Rosenthal AK, McLaughlin JK, Gridley G, Nyren O. Incidence of cancer among patients with systemic sclerosis. Cancer 1995; 76: 910-4.

  6. Rosenthal AK, McLaughlin JK, Linet MS, Persson I. Scleroderma and malignancy: an epidemiological study. Ann Rheum Dis 1993; 52: 531-3.

  7. Chatterjee S, Dombi G, Severson R, Mayes M. Risk of Malignancy in Scleroderma. Artritis Rheum 2005; 52: 2415-24.

  8. Bielefeld P. Systemic scleroderma and malignant diseases. A review of the literature. Rev Med Interne 1991; 12: 350-4.

  9. Mattingly PC, Mowat AG. Rapidly progressive scleroderma associated with carcinoma of the oesophagus. Ann Rheum Dis 1979: 38: 177-8.

  10. Derk CT, Rasheed M, Artlett CM, Jiménez SA. A cohort study of cancer incidence in systemic sclerosis. J Rheumatol 2006; 33: 1113-6.

  11. Launay D, Le Berre R, Hatron PY, Peyrat JP, Hachulla E, Devuelder B, et al. Association between systemic sclerosis and breast cancer: eight new cases and review of the literature. Clinic Rheumatol 2004; 23: 516-22.

  12. Derk CT. Associations of breast cancer development in patients with systemic sclerosis: an exploratory study. Clin Rheumatol 2007; 26: 1615-9.

  13. Hill CL, Nguyen A-M, Roder D, Robert-Thomson P. Risk of cancer in patients with scleroderma: a population based cohort study. Ann Rheum Dis 2003; 62: 728-31.

  14. Higuchi M, Horiuchi T, Ishibashi N, Yoshizawa S, Niho Y, Nagasawa K. Anticentromere antibody as a risk factor for cancer in patients with systemic sclerosis. Clin Rheumatol 2000; 19: 123-6.

  15. Chatterjee S, Severson RK, Weiss LK, Kau TY, Mayes MD. Risk of malignancy in scleroderma. Arthritis Rheum 2000; 43: S315.

  16. Black KA, Zilko PJ, Dawkins RL. Cancer in connective tissue disease. Artritis Rheum 1982; 25: 1130-3.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Med Cutan Iber Lat Am. 2009;37